CP 45959901
Latest Information Update: 23 Jul 2002
At a glance
- Originator Pfizer
- Developer Nonindustrial source
- Class
- Mechanism of Action Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Somatotropin deficiency
Most Recent Events
- 23 Jun 2000 Pfizer has merged with Warner-Lambert
- 22 May 2000 New profile
- 22 May 2000 Preclinical development for Somatotropin deficiency in United Kingdom (Unknown route)